- Se connecter
- Vérifiez maintenant
- Trading
- Recevoir le montant
| Heure | Prix le plus bas | prix le plus élevé | %Chg |
|---|---|---|---|
| 7 derniers jours | -- | -- | -- |
| 30 derniers jours | -- | -- | -- |
| 90 derniers jours | -- | -- | -- |
| 1 an | -- | -- | -- |
| Passé | -- | -- | -- |
Vaxcyte is a clinical-stage vaccine company that uses technologies such as cell-free protein synthesis to develop vaccines. Its lead candidates include VAX-31 and VAX-24, both designed to prevent invasive pneumococcal disease.

